Off-label use of recombinant factor VIIa in two tertiary hospitals in Queensland-Reference-Cited by-同舟云学术

Off-label use of recombinant factor VIIa in two tertiary hospitals in Queensland

Published:2012-11-09 Issue:3 Volume:83 Page:149-154
ISSN:1445-1433
Container-title:ANZ Journal of Surgery
language:en
Short-container-title:ANZ J Surg

Author:

Donovan Peter J.,Iedema Joel¹,McLeod Donald S.,Kubler Paul¹,Pillans Peter

Affiliation:

1. Department of Clinical Pharmacology; Royal Brisbane and Women's Hospital; Brisbane; Queensland; Australia

Publisher

Wiley

Subject

General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ans.12005/fullpdf

Reference23 articles.

1. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII;Hoffman;Blood Coagul. Fibrinolysis,1998

2. Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting;Logan;Hematology Am. Soc. Hematol. Educ. Program,2010

3. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials;Boffard;J. Trauma,2005

4. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery;Gill;Circulation,2009

5. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register;Isbister;Intern. Med. J.,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery;Journal of Cardiothoracic and Vascular Anesthesia;2019-05

2. Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery;Journal of the Saudi Heart Association;2016-10

3. x?;Therapeutic Innovation & Regulatory Science;2015-05

4. Recombinant factor VIIa use in patients presenting with intracranial hemorrhage;SpringerPlus;2014-08-27

5. Ethics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VII;Hastings Center Report;2014-02-14